The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index.


Updates from The Motley Fool

Latest updates on SPDR S&P Biotech from Fool.com.
Top Biotech ETFs to Buy

Not all biotech ETFs are alike. Here are the top 3 for investors to consider.

Last Week's Best Healthcare ETF

It was a terrific week to be a healthcare investor, but the performance of this one ETF was simpl...

Last Week's Best Healthcare ETF

Healthcare stocks had another good week, and investors in this one ETF made out especially well.

The Best ETFs for 2016

Are you on the hunt for a good ETF for the year ahead? Here are three names for you to consider.

November's Best Healthcare ETF

Many exchange traded funds that focus on the healthcare sector performed well in November, but on...

These 3 ETFs Jumped in November

Even as the stock market put in a tepid performance, these ETFs managed to produce sizable gains....

Last Week's Top Healthcare ETF

Healthcare stocks in general had another good week, but one exchange traded fund in particular pe...



Stock Performance

View Interactive XBI Charts
Sponsored by

Key Data Points

Primary metrics and data points about SPDR S&P Biotech.
Current Price: $88.92
Prev Close: $87.89
Open: $88.12
Bid: $88.61
Ask: $89.50
Day's Range: $87.73 - $89.02
52wk Range: $61.14 - $90.33
Volume: 2,645,723
Avg Vol 4,545,172
Market Cap: $4B
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.15 (0.2%)

Company Rating

What our community thinks about SPDR S&P Biotech.
CAPS Rating 0 out of 5
 
0 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think SPDR S&P Biotech will perform against the market?



You pick for SPDR S&P Biotech is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for SPDR S&P Biotech.

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index.

  • Exchange: NYSEMKT
  • Sector: Sector Equity
  • Industry: Health/Biotechnology Funds